Garnier L F, François G, Charbonnier B, Lang M, Raynaud P, Brochier M
Ann Cardiol Angeiol (Paris). 1987 Jun;36(6):313-7.
From 1982 to 1984 included, 31 patients under 70 years of age were admitted during the first three hours of a primary myocardial infarction (MI) and are the subject of a randomized prospective study. 16 patients are treated with 5,000 U of heparin given in intravenous bolus, followed with 150,000 IU of urokinase (UK) in intravenous bolus, then 12,000 IU of UK/min for 90 min or a total dose of 1,230,000 IU. 15 patients are treated with heparin alone (intravenous bolus of 5,000 U). Repeated titrations of creatine phosphokinase (CPK) and the coagulation parameters are performed during the first 24 hours. A coronary angiography with ventriculography (RAO 30 degrees) is performed on the 1st day (D1) and the 3rd week (W3). Study of the left ventricular kinetics (LV) is carried out according to the Stanford method. At D1, the rate of coronary patency is 56 p cent (n = 9) in the UK (A) group and 53 p. cent (n = 8) in the control group B (heparin alone). The percentage of late re-thrombosis is 0 p. cent in group A and 12.5 p. cent in group B (heparin alone). 1 patient died in each group. The CPK peak is less high in case of coronary patency in group A than in case of thrombosis (1,444 +/- 413 vs 1,710 +/- 120 U -heparin alone) and occurs earlier (16 +/- 2 h vs 21 +/- 1 h). In group A a significant decrease of fibrinogen (p. 0.01) as well as plasminogen and alpha-2-antiplasmins (p less than 0.001), is noted. No severe haemorrhagic complications nor sustained rhythm disorders are noted.(ABSTRACT TRUNCATED AT 250 WORDS)
在1982年至1984年期间,31名70岁以下的患者在首次心肌梗死(MI)发作的前三小时内入院,成为一项随机前瞻性研究的对象。16名患者接受静脉推注5000单位肝素治疗,随后静脉推注150000国际单位尿激酶(UK),然后以每分钟12000国际单位的速度输注90分钟,总剂量为1230000国际单位。15名患者仅接受肝素治疗(静脉推注5000单位)。在最初的24小时内对肌酸磷酸激酶(CPK)和凝血参数进行反复滴定。在第1天(D1)和第3周(W3)进行冠状动脉造影及心室造影(右前斜30度)。根据斯坦福方法对左心室动力学(LV)进行研究。在D1时,UK(A)组冠状动脉通畅率为56%(n = 9),对照组B(仅肝素)为53%。A组晚期再血栓形成百分比为0%,B组(仅肝素)为12.5%。每组各有1名患者死亡。A组冠状动脉通畅时CPK峰值低于血栓形成时(1444±413对1710±120单位 - 仅肝素),且出现时间更早(16±2小时对21±1小时)。在A组中,纤维蛋白原(p = 0.01)以及纤溶酶原和α2 - 抗纤溶酶显著降低(p小于0.001)。未观察到严重出血并发症和持续性心律失常。(摘要截取自250字)